These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28367260)

  • 41. AbobotulinumtoxinA Efficacy and Safety in Children With Equinus Foot Previously Treated With Botulinum Toxin.
    Dabrowski E; Bonikowski M; Gormley M; Volteau M; Picaut P; Delgado MR
    Pediatr Neurol; 2018 May; 82():44-49. PubMed ID: 29625849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multipoint and multilevel injection technique of botulinum toxin A in facial aesthetics.
    Iozzo I; Tengattini V; Antonucci VA
    J Cosmet Dermatol; 2014 Jun; 13(2):135-42. PubMed ID: 24910277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial.
    Zimbler MS; Holds JB; Kokoska MS; Glaser DA; Prendiville S; Hollenbeak CS; Thomas JR
    Arch Facial Plast Surg; 2001; 3(3):165-9. PubMed ID: 11497500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol.
    Esquenazi A; Ayyoub Z; Verduzco-Gutierrez M; Maisonobe P; Otto J; Patel AT
    Adv Ther; 2021 Nov; 38(11):5623-5633. PubMed ID: 34562231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison.
    Cruz F; Danchenko N; Fahrbach K; Freitag A; Tarpey J; Whalen J
    J Med Econ; 2023; 26(1):200-207. PubMed ID: 36647624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A two-phase, retrospective analysis evaluating efficacy of and patient satisfaction with abobotulinumtoxina used to treat dynamic facial rhytides.
    Kiripolsky MG; Peterson JD; Guiha I; Goldman MP
    Dermatol Surg; 2011 Oct; 37(10):1443-7. PubMed ID: 21649790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pain difference associated with injection of abobotulinumtoxinA reconstituted with preserved saline and preservative-free saline: a prospective, randomized, side-by-side, double-blind study.
    Allen SB; Goldenberg NA
    Dermatol Surg; 2012 Jun; 38(6):867-70. PubMed ID: 22268727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microtoxin for Improving Pore Size, Skin Laxity, Sebum Control, and Scars: A Roundtable on Integrating Intradermal Botulinum Toxin Type A Microdoses Into Clinical Practice.
    Fabi SG; Park JY; Goldie K; Wu W
    Aesthet Surg J; 2023 Aug; 43(9):1015-1024. PubMed ID: 36857534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sebum Production Alteration after Botulinum Toxin Type A Injections for the Treatment of Forehead Rhytides: A Prospective Randomized Double-Blind Dose-Comparative Clinical Investigation.
    Min P; Xi W; Grassetti L; Trisliana Perdanasari A; Torresetti M; Feng S; Su W; Pu Z; Zhang Y; Han S; Zhang YX; Di Benedetto G; Lazzeri D
    Aesthet Surg J; 2015 Jul; 35(5):600-10. PubMed ID: 25825422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids.
    Kassir R; Kolluru A; Kassir M
    Dermatol Ther (Heidelb); 2013 Dec; 3(2):179-89. PubMed ID: 24318416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microneedling Delivery of Botulinum Toxin Versus Intradermal Injection in the Treatment of Facial Hyperhidrosis.
    Ebrahim H; Nassar A; Mousa MM; Khater E
    J Clin Aesthet Dermatol; 2022 Sep; 15(9):40-44. PubMed ID: 36213604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Needle Size on Pain Perception in Patients Treated With Botulinum Toxin Type A Injections: A Randomized Clinical Trial.
    Alam M; Geisler A; Sadhwani D; Goyal A; Poon E; Nodzenski M; Schaeffer MR; Tung R; Minkis K
    JAMA Dermatol; 2015 Nov; 151(11):1194-9. PubMed ID: 26352252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines.
    Kim JE; Song EJ; Choi GS; Lew BL; Sim WY; Kang H
    Plast Reconstr Surg; 2015 Mar; 135(3):732-741. PubMed ID: 25719692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2).
    Bertucci V; Solish N; Kaufman-Janette J; Yoelin S; Shamban A; Schlessinger J; Snyder D; Gallagher C; Liu Y; Shears G; Rubio RG
    J Am Acad Dermatol; 2020 Apr; 82(4):838-845. PubMed ID: 31791824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Pilot Study to Evaluate the Efficacy and Safety of Treatment with Botulinum Toxin in Patients with Recalcitrant and Persistent Erythematotelangiectatic Rosacea.
    Park KY; Kwon HJ; Kim JM; Jeong GJ; Kim BJ; Seo SJ; Kim MN
    Ann Dermatol; 2018 Dec; 30(6):688-693. PubMed ID: 33911508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A.
    Chang SP; Tsai HH; Chen WY; Lee WR; Chen PL; Tsai TH
    Int J Dermatol; 2008 Dec; 47(12):1287-94. PubMed ID: 19126019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure of botulinum toxin injection for neurogenic detrusor overactivity: Switch of toxin versus second injection of the same toxin.
    Peyronnet B; Castel-Lacanal E; Manunta A; Roumiguié M; Marque P; Rischmann P; Gamé X
    Int J Urol; 2015 Dec; 22(12):1160-5. PubMed ID: 26391575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fields of effects of 2 commercial preparations of botulinum toxin type A at equal labeled unit doses: a double-blind randomized trial.
    Hexsel D; Hexsel C; Siega C; Schilling-Souza J; Rotta FT; Rodrigues TC
    JAMA Dermatol; 2013 Dec; 149(12):1386-91. PubMed ID: 24108521
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.